Etanercept concentrations in maternal serum, umbilical cord serum, breast milk and child serum during breastfeeding

Rheumatology

Volumn 49, Issue 11, 2010, Pages 2225-2227

  Berthelsen, Birgitte G ^a   Fjeldsøe Nielsen, Hans ^b   Nielsen, Christoffer T ^c   Hellmuth, Ellinor ^d  

^a General Practice   (Denmark)

^b NAESTVED HOSPITAL   (Denmark)

^c STATENS SERUM INSTITUT   (Denmark)

^d University of Copenhagen   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ETANERCEPT;

ABSENCE OF SIDE EFFECTS; ADULT; ANKYLOSING SPONDYLITIS; BLOOD SAMPLING; BREAST FEEDING; BREAST MILK; CASE REPORT; DELIVERY; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; FEMALE; HUMAN; LETTER; MATERNAL BLOOD; NEWBORN; PLACENTAL TRANSFER; PREGNANCY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PUERPERIUM; UMBILICAL CORD BLOOD;

ADULT; BLOOD; BREAST FEEDING; FEMALE; HUMANS; INFANT; MATERNAL-FETAL EXCHANGE; MILK, HUMAN; PLACENTA; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TUMOR NECROSIS FACTOR-ALPHA; UMBILICAL CORD;

EID: 78649349573     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/keq185     Document Type: Letter

References (5)

1. Murashima A, Watanabe N, Ozawa N. Etanercept during pregnancy and lactation in a patient with rheumatoid arthritis: drug levels in maternal serum, cord blood, breast milk and the infant's serum. Ann Rheum Dis 2009;68: 1793-4.
2. Ostensen M, Eigenmann GO. Etanercept in breast milk. J Rheumatol 2004;31:1017-8.
3. Ostensen M, Forger F. Management of RA medications in pregnant patients. Nat Rev Rheumatol 2009;5:382-90.
4. Svenson M, Geborek P, Saxne T, Bendtzen K. Monitoring patients treated with anti-TNF-alpha biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies. Rheumatology 2007;46:1828-34.
5. Zhou H, Buckwalter M, Boni J et al. Population-based pharmacokinetics of the soluble TNFr etanercept: a clinical study in 43 patients with ankylosing spondylitis compared with post hoc data from patients with rheumatoid arthritis. Int J Clin Pharmacol Ther 2004;42:267-76.